natgillin/translations-raw huggingface dataset:
poudarja, da je eden najpomembnejših vidikov za ustrezno reševanje problema morebitne pandemije aviarne gripe pri ljudeh ta, da so na voljo točne, znanstveno dokazane informacije o zdravilih, cepivih, naravni odpornosti proti bolezni, pa tudi zanesljivi epidemiološki podatki;
Stresses that one of the most important aspects of properly dealing with the problem of a possible human avian influenza pandemic is having the correct, scientifically proven, information regarding drugs, vaccines, natural resistance to the disease as well as reliable epidemiological data;
pozdravlja delo ECDC pri prepoznavanju, ocenjevanju in zagotavljanju informacij o grožnjah, povezanih z gripo, in njegovo zavezanost, da državam članicam in Komisiji pomaga pri preprečevanju izbruha pandemije; poudarja, da bi bilo treba zagotoviti zadostna sredstva za delovanje ECDC;
Welcomes the ECDC 's work in identifying, assessing and providing information on influenza-related threats and its commitment to helping Member States and the Commission prevent a pandemic outbreak; stresses that sufficient funding should be guaranteed for the ECDC's operations;
poudarja, da mora imeti Komisija pomembno vlogo pri usklajevanju med državami članicami glede vseh dejavnosti, povezanih s pripravljenostjo na pandemijo v Evropski uniji, in da bi morala okrepiti zmogljivosti ECDC za določanje glavnih ukrepov za javno zdravje, ki jih je treba sprejeti v primeru pandemije;
Stresses that the Commission must play a strong coordinating role between the Member States in all activities relating to pandemic preparedness in the European Union and that it should strengthen the ECDC 's capacity to identify the key public health measures that must be taken in the event of a pandemic;
poziva Komisijo in države članice, naj upoštevajo pomembne ugotovitve, poročila in preiskave s krajev samih, ki jih je pripravil ECDC, ter zagotovijo, da države članice, ki nimajo zadovoljivih načrtov za boj proti pandemiji, te dopolnijo in izboljšajo, saj morajo biti zaradi narave tveganja vse države članice polno pripravljene;
Calls on the Commission and the Member States to take account of the relevant observations, reports and on-the-spot investigations of the ECDC and to ensure that those Member States whose planning to combat a pandemic is substandard supplement and upgrade their plans, since the nature of the risk is such that all Member States must be fully prepared;
meni, da bi morala biti Komisija v primeru pandemije gripe v EU ali v sosednjih državah sposobna v 24 urah sprejeti krizne ukrepe, kot so karantena, razkuževalni ukrepi na letališčih pri letih z določenih območij in omejitev potovanj;
Considers that, in the event of an influenza pandemic in the EU or in neighbouring States, the Commission should within 24 hours be able to adopt crisis measures such as quarantine and disinfection measures at airports in connection with flights from certain regions and travel restrictions;
meni, da obstaja v državah članicah potreba po močni politični zavezanosti za načrtovanje pripravljenosti, po povečevanju sredstev in raziskav, rešitvi zapletenih pravnih in etičnih vprašanj ter oblikovanju skupnih rešitev in čezmejnega sodelovanja;
Considers that there is a need for strong political commitment in the Member States to preparedness planning, increasing resources and research, the resolution of complex legal and ethical issues, and developing common solutions and cross-border cooperation;
poudarja, da je treba ukrepati hitro in odločno, da bi omejili aviarno gripo in tako preprečili pandemijo pri ljudeh, in sicer najprej glede zdravja živali, saj je to primarni vir tveganja, ter da je treba sprejeti tudi bistvene ukrepe, vključno s popolno oceno števila bolnišničnih postelj na ravni držav članic, za pripravo na možnost pandemije pri ljudeh, zato da bodo na razpolago sredstva za njeno obvladovanje, če bi do nje prišlo; meni, da bi bilo treba posebno pozornost nameniti povečevanju zmogljivosti za izdelavo cepiv in protivirusnih zdravil za primer pandemije v državah članicah in na evropski ravni ter krepitvi infrastrukture v sektorju zdravja živali in sektorju javnega zdravja; meni, da bi morala Evropska unija v zvezi s tem zagotoviti logistično in finančno pomoč pri razvoju cepiv;
Emphasises that rapid and decisive action must be taken to control avian influenza and so prevent a human pandemic, first of all with respect to animal health, as this is the primary source of risk, and that significant measures, including a full assessment of hospital bed capacity at Member State level, must also be taken to prepare for a possible human pandemic, so that the means to control it, should it occur, are available; considers that particular attention should be paid to developing further the capacity to produce pandemic vaccines and anti-virals in Member States and at European level and strengthening the infrastructure in the animal and public health sectors; considers that, in this connection, the European Union should provide logistic and financial assistance with the development of vaccines;
poudarja, da so simulacijske vaje za pandemijo gripe bistvene za preverjanje učinkovitosti načrtov pripravljenosti v posameznih državah članicah in da bi jih bilo treba izvajati redno, kot previdnostni ukrep, tudi če ni izbruha pandemije; poudarja, da bodo rezultati in znanje, pridobljeno na teh vajah, pomembni za prizadevanja za izboljšanje načrtov in njihove interoperabilnosti;
Points out that pandemic influenza simulation exercises are vital in order to test the effectiveness of each Member State's national pandemic influenza plans and that they should be conducted regularly, as a precautionary measure, even if there is no pandemic outbreak; emphasises that the results of and lessons learned from these exercises will be important to the efforts to improve plans and their interoperability;
poudarja, da bi bilo treba simulacijske vaje razširiti na odročne regije in podeželje;
Stresses that these simulation exercises should be extended to outlying regions and rural areas;
priznava, da je potrebno pripraviti in uvesti podrobne scenarije za zaščito otrok in mladine pred virusom aviarne gripe tipa A (H5N1);
Acknowledges the need for detailed scenarios for the protection of children and young people against the avian influenza A virus (H5N1) to be drawn up and introduced;
poudarja, da je treba okrepiti sisteme za nadzor, hitro obveščanje in sisteme za opozarjanje, analizo podatkov ter epidemiologijo za bolezni ljudi in živali, da bi omogočili zgodnje odkrivanje in prepoznavanje okužbe pri živalih in ljudeh ter zagotovili hitro izvajanje učinkovitih protiukrepov;
Emphasises that there is a need to strengthen surveillance systems, rapid reporting and alerting systems, data analysis and epidemiology for animal and human diseases, so as to enable the early detection and identification of avian and human infection and to enable the rapid implementation of effective counter-measures;
poudarja, da je obenem potrebna tudi hitra ocena neposrednih socialno-ekonomskih posledic aviarne gripe ter vprašanj glede nadomestil in z njimi povezanih pobud;
Stresses that, at the same time, rapid assessment is required of the immediate socio-economic impact of avian influenza and of compensation issues and associated incentives;
pozdravlja nedvoumno zavezanost držav članic, Komisije in ECDC k preglednosti in izmenjavi informacij ter poudarja pomen hitre izmenjave informacij in bioloških vzorcev iz domnevnih ali potrjenih primerov pri ljudeh in živalih, da bi omogočili ustrezno in vsestransko pripravljenost in odziv; poziva k tesnejšemu sodelovanju med referenčnimi laboratoriji, da bi pospešili identifikacijo virusov in stalno nadzorovali morebitne mutacije;
Welcomes the unequivocal commitment to transparency and information sharing made by the Member States, the Commission and the ECDC and emphasises the importance of rapid sharing of information and of biological specimens derived from suspected and confirmed cases among humans and animals so as to facilitate adequate and comprehensive preparedness and response; calls for the strengthening of cooperation between reference laboratories to speed up the identification of viruses and maintain constant monitoring of any possible mutations;
poziva Komisijo, ECDC in države članice, naj vzpostavijo sistem za nadaljnjo izmenjavo informacij med seboj in prizadetimi državami ter tako pripomorejo k oblikovanju najboljših praks;
Urges the Commission, the ECDC and the Member States to put in place a system for the continuous exchange of information between them and affected countries and thus to assist in the development of best practices;
ugotavlja, da bi bilo treba po vzoru ECDC izboljšati komunikacijske strategije na nacionalni in evropski ravni ter vanje vključiti redno objavljanje poročil na internetu, uporabo e-pošte ali omejenih spletnih strani za strokovnjake in medije;
Notes that, following the example of the ECDC, communication strategies at national and European level should be improved and should include the publishing of regular reports on the Internet, the use of e-mails or restricted websites for professionals and the media;
vendar poudarja, da bi morale države članice preučiti, kako bi se najbolje približale državljanom, tako da bi informacije dosegle celotno prebivalstvo, vključno s starejšimi, mladimi, nepismenimi ali tistimi, ki nimajo dostopa do sodobnih sredstev komunikacije;
Stresses however that Member States should examine the best ways of approaching their citizens, so that information reaches the whole population, including the old, the young, the illiterate or those who do not have access to modern means of communication;
poudarja pomen izobraževanja in pravilnega obveščanja v primeru kriz ter da bi morala primerna navodila poleg spoštovanja pravil higiene zajemati tudi informacije npr. o mobilnosti, transportu in zaposlovanju;
Stresses the importance of education and correct information in the event of crises and that appropriate instructions should cover not only compliance with hygiene rules but also the provision of information in areas such as mobility, transport and employment;
poziva, naj evropski nadzorni sistem zagotavlja zanesljive informacije o nevarnosti pandemije;
Calls for reliable information on the threat of a pandemic to be provided through the European supervisory system;
priznava, da je krepitev komunikacije z nacionalnimi instituti, pristojnimi za nadzor nad javnim zdravjem, mogoče doseči z razvojem sistema zgodnjega opozarjanja in odzivanja, ki bi ga ECDC vodil za usklajevanje ocenjevanja tveganja in spremljanja;
Acknowledges that a potential solution for strengthening communication with national institutes responsible for public health surveillance is to develop an early warning and response system to be operated by the ECDC for the coordination of risk assessment and monitoring;
poudarja, da bi morale Komisija in države članice zagotoviti dovolj sredstev, da bi ljudem omogočile primernejše, razumljivejše in oprijemljivejše informacije ter s tem povečale ozaveščenost javnosti;
Stresses that sufficient funds should be made available by the Commission and the Member States in order to provide people with more pertinent, understandable and tangible information and thus raise public awareness;
poziva k dobro strukturiranemu in multidisciplinarnemu sodelovanju strokovnjakov na področju zdravja ljudi in živali, specialistov za virologijo, epidemiologijo, patologijo in kmetijstvo ter komunikacijskih strokovnjakov in strokovnjakov za prenašanje znanosti v politiko na globalni ravni; zato predlaga oblikovanje evropske delovne skupine za gripo, ki jo usklajuje Komisija s predstavniki Evropskega parlamenta in v kateri bi bila vsa omenjena strokovna področja združena na evropski ravni; poudarja, da bi morala ta delovna skupina sodelovati s predstavniki evropske industrije cepiv in protivirusnih zdravil;
Calls for well-structured and multidisciplinary collaboration among experts in human and animal health, specialists in the fields of virology, epidemiology, pathology and agriculture, as well as communication experts and experts in translating science into policy at a global level; suggests, therefore, the creation of a European Influenza Task Force, coordinated by the Commission, on which the European Parliament is represented and in which all the above-mentioned fields of expertise are brought together at European level; emphasises that this Task Force should work together with representatives of European vaccine and antiviral industries;
poziva, naj se nemudoma uvedejo evropski raziskovalni in razvojni programi za pojavljajoče se bolezni, da bi zanesljivo in hitreje razvili protivirusna zdravila, antibiotike in cepiva;
Urges that European research and development programmes on emergent diseases be launched immediately to develop antivirals, antibiotics and vaccines reliably and more quickly;
poudarja, da mora načrtovanje in ocenjevanju nacionalnih načrtov za pripravljenost na pandemijo zajemati več sektorjev in vključevati vsa zadevna ministrstva in zainteresirane strani; poudarja pomen vnaprejšnjega naročanja cepiv;
Emphasises that the planning and assessment of national pandemic preparedness plans must be multi-sectoral and involve all relevant ministries and stakeholders; stresses the importance of ordering vaccines in advance;
opozarja evropske organe in organe v državah članicah, da je zaželeno povečati zaloge antibiotikov za zdravljenje zapletov, povezanih z gripo;
Draws the attention of European authorities and those of the Member States to the desirability of consolidating stocks of antibiotics to treat complications of influenza;
poudarja, da obstoječa mreža za spremljanje, oblikovana s sofinanciranjem Skupnosti (European Influenza Surveillance Scheme, EISS), predstavlja dobro osnovo za opravljanje te ključne naloge, vendar bi jo bilo treba nadaljnje razviti in podpirati, kar velja tudi za mrežo laboratorijev za gripo v Skupnosti;
Stresses that the existing surveillance network established through Community co-funding (European Influenza Surveillance Scheme, EISS) provides a good basis for carrying out this crucial task but needs to be further developed and supported, as should the network of laboratories dealing with influenza in the Community;
poudarja, da je načrtovanje za pridobivanje in uporabo cepiv za primer pandemije v večini držav še premalo razvito in bi bilo zato treba v skladu s priporočili Svetovne zdravstvene organizacije sprejeti ukrepe za njegov nadaljnji razvoj z dodelitvijo naloge Komisiji, naj naroči cepiva in pripravi zaloge Skupnosti;
Stresses that planning for obtaining and using pandemic vaccines is in most countries underdeveloped and measures should thus be taken to further develop it in accordance with WHO recommendations by giving the Commission a mandate to order vaccines and establish a Community stockpile;
poziva Komisijo, naj se poveže z izdelovalci cepiv, da bi ocenila napredek glede povečanja zmogljivosti izdelovanja cepiv in pravične dobave v primeru pandemije, in naj skupaj z državami članicami obravnava vprašanja odgovornosti in oblikovanje evropskega mehanizma za pravično porazdelitev cepiv za pandemijo, s katerim ne bodo kršeni pogodbeni dogovori držav članic;
Calls on the Commission to liaise with vaccine manufacturers to evaluate progress towards vaccine production capacity increase and equity of supply in pandemic situations and to address, together with the Member States, questions of liability and the establishment of a European mechanism for equitable distribution of pandemic vaccines that does not breach contractual agreements established by Member States;
meni, da bi morala Komisija ukreniti vse potrebno, da bo na voljo dovolj protivirusnih zdravil in cepiv za vse, ki so ob izbruhu v eni ali več državah članicah izpostavljeni virusu;
Considers that the Commission should take steps to ensure that sufficient antivirals and vaccines are available for those who are exposed to the virus in the event of an outbreak in one or more Member States;
poudarja vlogo Evropske agencije za zdravila (EMEA) pri določanju uporabe in učinkovitosti protivirusnih zdravil in cepiv za primer pandemije ter pri prepoznavanju in raziskovanju morebitnih škodljivih učinkov ali poročil o nasprotovanju jemanja zdravil; s tem v zvezi poziva k hitri uvedbi postopka za "pogojno dovoljenje" iz člena 14(7) Uredbe (ES) št. 726/2004 Evropskega parlamenta in Sveta z dne 31. marca 2004 o postopkih Skupnosti za pridobitev dovoljenja za promet in nadzor zdravil za humano in veterinarsko uporabo ter o ustanovitvi Evropske agencije za zdravila UL L 136, 30.4.2004, str.
Emphasises the role of the European Medicines Agency, EMEA, in determining the use and effectiveness of anti-virals and pandemic vaccines, as well as its role in detecting and investigating any adverse effects or reports of reluctance to take medication; calls in this connection for the early establishment of the 'conditional authorisation' procedure provided for in Article 14(7) of Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency OJ L 136, 30.4.2004, p.
poziva države članice, naj v skladu s priporočili Svetovne zdravstvene organizacije povečajo naročila za sezonsko cepljenje proti gripi in s tem pomagajo farmacevtski industriji povečati proizvodne zmogljivosti za cepiva proti gripi, da bi zmogla zadostiti bistveno večjemu povpraševanju, ki bi ga povzročila pandemija gripe;
Calls on Member States to increase orders of seasonal influenza vaccines in line with WHO recommendations to assist the pharmaceutical industry in increasing the production capacity of influenza vaccines, in order to cope with the substantial increase in demand that an influenza pandemic would bring;
poziva Evropsko unijo, naj ukrene vse potrebno za zadostne zaloge protivirusnih zdravil ter naj s proizvajalci protivirusnih zdravil uvede obvezni licenčni sistem, da bi zagotovili njihovo množično proizvodnjo; poziva države, naj zagotovijo potencialno pokritost 25 do 30 % prebivalstva z razpoložljivimi protivirusnimi zdravili;
Calls on the European Union to take the necessary measures to obtain adequate stocks of antivirals and to establish a compulsory licensing system with businesses which produce antivirals to guarantee mass production of these antivirals; calls on countries to provide for potential cover for 25 to 30% of the population with available antivirals:
poudarja, da je popolno, natančno in praktično izvajanje nacionalne zakonodaje s prenašanjem direktiv Skupnosti o zdravju in varnosti pri delu v nacionalno pravo bistveno za zagotavljanje ustreznega varstva delavcev, zlasti tistih v skupini z visokim tveganjem za okužbo; poudarja, da morajo delodajalci izpolnjevati specifične obveznosti, ki jih določa pravo Skupnosti (npr. izogibanje tveganju, ocenjevanje tveganja, ukrepi za preprečevanje in zaščito) v skladu z Direktivo 2000/54/ES Evropskega parlamenta in Sveta z dne 18. septembra 2000 o varovanju delavcev pred tveganji povezanimi z izpostavljenostjo biološkim dejavnikom pri delu UL L 262, 17.10.2000, str.
Stresses that full, accurate and practical implementation of the national legislation transposing the Community directives on health and safety at work is of vital importance in ensuring the adequate protection of workers, particularly those in high infection risk groups; emphasises that employers must fulfil their specific obligations laid down by Community law (for example risk avoidance, risk assessment, prevention and protection measures), in accordance with Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work OJ L 262, 17.10.2000, p.
poudarja, da bi bilo treba politično in znanstveno zavezanost izraziti z zagotavljanjem človeških in finančnih virov in s podporo raziskavam in razvoju, da bi spodbudili nove, hitre metode izdelovanja protivirusnih zdravil in cepiv, ki bi lahko zadostile povečanim potrebam ob pandemiji, zlasti pa v boju proti novim sevom virusov;
Stresses that political and scientific commitment should be translated into the provision of human and financial resources and support for research and development in order to promote new, swift methods of producing antiviral drugs and vaccines with the capacity to meet the greater needs arising in a pandemic, particularly to combat new strains of viruses;
pozdravlja predlog uredbe o ustanovitvi Solidarnostnega sklada Evropske unije ( KOM(2005)0108 ), zlasti pa določbe o nujnih primerih za javno zdravje in ukrepih za zaščito prebivalstva pred neposredno nevarnostjo za zdravje, vključno s pokritjem stroškov za cepiva in preskrbo z zdravili, opremo in infrastrukturo;
Welcomes the proposal for a regulation establishing the Solidarity Fund ( COM(2005)0108 ) and in particular its provisions concerning public health emergencies and measures to protect the population against imminent health threats, including meeting the cost of vaccines and the supply of medical products, equipment and infrastructure;
poudarja, da bi moralo biti v sedmem okvirnem raziskovalnem programu poskrbljeno za ustrezna sredstva za podporo projektom, ki obravnavajo razne vidike pandemije gripe in drugih epidemij, vključno s skupnimi raziskavami s farmacevtskimi podjetji o cepivih na podlagi celic in DNK;
Points out that adequate funding should be provided in the 7th Research Framework Programme in order to support projects addressing various aspects of pandemic influenza and other epidemics including joint research with pharmaceutical companies on cell-based and DNA vaccines;
pozdravlja zavezanost Komisije, da bo tretjim državam za boj proti gripi namenila 80 milijonov EUR, nadaljnjih 20 milijonov EUR pa za sredstva za raziskave iz šestega okvirnega raziskovalnega programa, s čimer celotna obveznost Komisije znaša 100 milijonov EUR;
Welcomes the Commission's pledge of EUR 80 million to third countries to combat influenza and a further EUR 20 million to research funds earmarked from the 6th Research Framework Programme, bringing the total Commission pledge to EUR 100 million;
poziva Komisijo, naj si po donatorski konferenci v Pekingu prizadeva za skladnejši mednarodni okvir, ki bi presegel krizno upravljanje in obravnaval vprašanja, kako vzpostaviti boljšo infrastrukturo za zdravje živali v državah v razvoju, kot tudi pospešil raziskovanje izdelkov za zdravje živali, ki bi jih bilo mogoče uporabiti v razvitih državah in v državah v razvoju;
Urges the Commission to work for a more coherent international framework in the follow-up of the Beijing pledging conference that goes beyond crisis management and addresses the issues of building up a better infrastructure for animal health in developing countries, as well as advancing research in animal health products that can be used in developed as well as developing countries;
poziva Komisijo, naj preuči, kako ob izbruhu pandemije ohraniti nemoteno delovanje osnovnih storitev, kot so trgovine, banke, bolnišnice in druge;
Calls on the Commission to study ways of maintaining smoothly operating essential services, such as markets, banks, hospitals, and others, in the event of a pandemic outbreak;
poudarja, da je treba poskrbeti za zadostno finančno podporo v okviru mednarodnega sodelovanja z azijskimi in afriškimi državami, ki so trenutno prizadete zaradi aviarne gripe, da se izboljša njihova zmožnost spremljanja in nadzora nad boleznimi;
Stresses that sufficient financial support must be provided in the context of international collaboration with Asian and African countries currently affected by avian influenza, to improve their surveillance and disease control capacities;